The first generic version of Accutane (isotretinoin), approved Nov. 11 by the FDA, reached market in late November at a price approximately 5.5 percent lower than the brand name.
Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
The Weekly Roundup: September 18-22
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children
Combination Treatments in HS Require Further Review